Teriparatide (PTH 1-34) studies: 484 papers with results
Page 4 of 10
- Serum 25-hydroxy-vitamin D and the risk of fractures in the teriparatide versus risedronate VERO clinical trial.
Minisola S · Archives of osteoporosis · 2019
Randomized controlled trial · 3 results
- Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study.
Lu C · Clinical interventions in aging · 2017
Randomized controlled trial · 8 results
- Comparative bone histomorphometry effects of combined denosumab and teriparatide vs monotherapy in postmenopausal women with osteoporosis: a randomized controlled trial.
Ramchand SK · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
Randomized controlled trial · 8 results
- Impact of standard versus cyclic teriparatide and denosumab treatment on trabecular bone score: a post-hoc analysis of a randomized clinical trial.
Dash AS · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
Randomized controlled trial · 8 results
- Teriparatide and osseous regeneration in the oral cavity.
Bashutski JD · The New England journal of medicine · 2010
Non-randomized trial · 5 results
- Assessing the Effects of Teriparatide Treatment on Bone Mineral Density, Bone Microarchitecture, and Bone Strength.
Kleerekoper M · The Journal of bone and joint surgery. American volume · 2014
Non-randomized trial · 12 results
- Teriparatide for idiopathic osteoporosis in premenopausal women: a pilot study.
Cohen A · The Journal of clinical endocrinology and metabolism · 2013
Non-randomized trial · 17 results
- Teriparatide Followed by Denosumab in Premenopausal Idiopathic Osteoporosis: Bone Microstructure and Strength by HR-pQCT.
Agarwal S · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2023
Non-randomized trial · 23 results
- Spine Volumetric BMD and Strength in Premenopausal Idiopathic Osteoporosis: Effect of Teriparatide Followed by Denosumab.
Agarwal S · The Journal of clinical endocrinology and metabolism · 2022
Non-randomized trial · 9 results
- Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis.
Boonen S · The Journal of clinical endocrinology and metabolism · 2008
Non-randomized trial · 7 results
- Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women--the six-month effect of risedronate and teriparatide.
Polyzos SA · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2012
Non-randomized trial · 1 result
- Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate.
Ettinger B · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2004
Non-randomized trial · 9 results
- Assessing the effect of baseline status of serum bone turnover markers and vitamin D levels on efficacy of teriparatide 20 μg/day administered subcutaneously in Japanese patients with osteoporosis.
Yamamoto T · Journal of bone and mineral metabolism · 2013
Non-randomized trial · 1 result
- Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover.
Delmas PD · Bone · 2006
Non-randomized trial · 4 results
- Active comparator trial of teriparatide vs alendronate for treating glucocorticoid-induced osteoporosis: results from the Hispanic and non-Hispanic cohorts.
Losada BR · Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry · 2009
Non-randomized trial · 7 results
- Bone density after teriparatide in patients with or without prior antiresorptive treatment: one-year results from the EUROFORS study.
Minne H · Current medical research and opinion · 2008
Non-randomized trial · 7 results
- Randomized crossover comparison of two teriparatide self-injection regimens for primary osteoporosis: final report of the Japanese Osteoporosis Intervention Trial 06 (JOINT-06).
Tanaka S · Journal of bone and mineral metabolism · 2025
Non-randomized trial · 8 results
- Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis.
Recker RR · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2009
Non-randomized trial · 6 results
- Teriparatide versus low-dose bisphosphonates before and after surgery for adult spinal deformity in female Japanese patients with osteoporosis.
Seki S · European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2017
Non-randomized trial · 5 results
- Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study.
Ohtori S · Spine · 2012
Non-randomized trial · 3 results
- Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis.
Ma YL · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2006
Non-randomized trial · 8 results
- Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis.
Keaveny TM · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2007
Non-randomized trial · 4 results
- Quantitative computed tomographic assessment of the effects of 24 months of teriparatide treatment on 3D femoral neck bone distribution, geometry, and bone strength: results from the EUROFORS study.
Borggrefe J · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2010
Non-randomized trial · 8 results
- Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure.
Jiang Y · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2003
Non-randomized trial · 9 results
- Comparative effects of teriparatide and strontium ranelate in the periosteum of iliac crest biopsies in postmenopausal women with osteoporosis.
Ma YL · Bone · 2011
Non-randomized trial · 15 results
- Effects of Weekly Teriparatide Administration for Vertebral Stability and Bony Union in Patients with Acute Osteoporotic Vertebral Fractures.
Kitaguchi K · Asian spine journal · 2019
Non-randomized trial · 3 results
- Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment.
Ma YL · Bone · 2014
Non-randomized trial · 12 results
- Changes in cross-sectional area of spinal canal and vertebral body under 2 years of teriparatide treatment: results from the EUROFORS study.
Schnell R · Calcified tissue international · 2010
Non-randomized trial · 3 results
- Comparison of teriparatide and bisphosphonate treatment to reduce pedicle screw loosening after lumbar spinal fusion surgery in postmenopausal women with osteoporosis from a bone quality perspective.
Ohtori S · Spine · 2013
Non-randomized trial · 2 results
- PTH(1-34) for Surgical Hypoparathyroidism: A 2-Year Prospective, Open-Label Investigation of Efficacy and Quality of Life.
Palermo A · The Journal of clinical endocrinology and metabolism · 2018
Non-randomized trial · 7 results
- PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life.
Santonati A · The Journal of clinical endocrinology and metabolism · 2015
Non-randomized trial · 6 results
- Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium.
Lindsay R · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2007
Non-randomized trial · 6 results
- Remodeling- and Modeling-Based Bone Formation With Teriparatide Versus Denosumab: A Longitudinal Analysis From Baseline to 3 Months in the AVA Study.
Dempster DW · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2018
Non-randomized trial · 7 results
- The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis.
Anastasilakis AD · Clinical endocrinology · 2010
Non-randomized trial · 2 results
- Changes of Circulating MicroRNAs in Response to Treatment With Teriparatide or Denosumab in Postmenopausal Osteoporosis.
Anastasilakis AD · The Journal of clinical endocrinology and metabolism · 2018
Non-randomized trial · 2 results
- Retreatment with teriparatide one year after the first teriparatide course in patients on continued long-term alendronate.
Cosman F · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2009
Non-randomized trial · 4 results
- Effective ancillary role and long-term course of daily or weekly teriparatide treatment on refractory medication-related osteonecrosis of the jaw: a clinical case series.
Yoshiga D · The British journal of oral & maxillofacial surgery · 2022
Non-randomized trial · 4 results
- No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial.
Anastasilakis AD · Clinical endocrinology · 2009
Non-randomized trial · 3 results
- Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate.
Gamsjaeger S · Bone · 2011
Non-randomized trial · 3 results
- Effects of 1 year of daily teriparatide treatment on iliacal bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women previously treated with alendronate or risedronate.
Misof BM · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2010
Non-randomized trial · 10 results
- A small dose of human parathyroid hormone(1-34) increased bone mass in the lumbar vertebrae in patients with senile osteoporosis.
Sone T · Mineral and electrolyte metabolism · 1995
Non-randomized trial · 4 results
- Rapid and robust response of biochemical markers of bone formation to teriparatide therapy.
Glover SJ · Bone · 2009
Non-randomized trial · 5 results
- A comparison of the in vivo biochemical responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man.
Fraher LJ · The Journal of clinical endocrinology and metabolism · 1992
Non-randomized trial · 11 results
- Responses to Treatment With Teriparatide in Patients With Atypical Femur Fractures Previously Treated With Bisphosphonates.
Watts NB · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2017
Non-randomized trial · 5 results
- Teriparatide treatment in adult patients with osteogenesis imperfecta type I.
Gatti D · Calcified tissue international · 2013
Non-randomized trial · 6 results
- Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis.
Macdonald HM · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2011
Non-randomized trial · 8 results
- Subcutaneous administration of the amino-terminal fragment of human parathyroid hormone-(1-34): kinetics and biochemical response in estrogenized osteoporotic patients.
Lindsay R · The Journal of clinical endocrinology and metabolism · 1993
Non-randomized trial · 9 results
- Healing of erosions in rheumatoid arthritis remains elusive: results with 24 months of the anabolic agent teriparatide.
Duryea J · Scandinavian journal of rheumatology · 2021
Non-randomized trial · 5 results
- A Longitudinal Study of Skeletal Histomorphometry at 6 and 24 Months Across Four Bone Envelopes in Postmenopausal Women With Osteoporosis Receiving Teriparatide or Zoledronic Acid in the SHOTZ Trial.
Dempster DW · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2016
Non-randomized trial · 10 results
- Assessment of regional changes in skeletal metabolism following 3 and 18 months of teriparatide treatment.
Moore AE · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2010
Non-randomized trial · 9 results